Nephros Historical Financial Ratios
| NEPH Stock | USD 1.64 0.03 1.86% |
Nephros is lately reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 36.43 will help investors to properly organize and evaluate Nephros financial condition quickly.
Nephros |
About Nephros Financial Ratios Analysis
NephrosFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nephros investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nephros financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nephros history.
Nephros Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nephros stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nephros sales, a figure that is much harder to manipulate than other Nephros multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Nephros dividend as a percentage of Nephros stock price. Nephros dividend yield is a measure of Nephros stock productivity, which can be interpreted as interest rate earned on an Nephros investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Operating Cash Flow
A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.Most ratios from Nephros' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nephros current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.As of now, Nephros' Operating Cash Flow Per Share is increasing as compared to previous years. The Nephros' current Average Payables is estimated to increase to about 1.2 M, while Price To Sales Ratio is projected to decrease to 2.40.
| 2023 | 2024 (projected) | Dividend Yield | 0.011 | 0.0144 | Price To Sales Ratio | 2.52 | 2.4 |
Nephros fundamentals Correlations
Click cells to compare fundamentals
Nephros Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nephros fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 7.26 | 9.1 | 5.68 | 1.2 | 2.52 | 2.4 | |
| Ptb Ratio | 16.05 | 6.22 | 5.05 | 2.14 | 4.3 | 3.48 | |
| Days Sales Outstanding | 44.86 | 58.15 | 57.57 | 47.06 | 38.35 | 36.43 | |
| Book Value Per Share | 1.02 | 1.72 | 1.47 | 0.86 | 0.8 | 0.84 | |
| Free Cash Flow Yield | (0.0305) | (0.0917) | (0.0246) | (0.28) | 0.0209 | 0.022 | |
| Operating Cash Flow Per Share | (0.3) | (0.76) | (0.14) | (0.31) | 0.0796 | 0.0836 | |
| Stock Based Compensation To Revenue | 0.17 | 0.13 | 0.091 | 0.0984 | 0.0739 | 0.0702 | |
| Pb Ratio | 16.05 | 6.22 | 5.05 | 2.14 | 4.3 | 3.48 | |
| Ev To Sales | 7.11 | 8.39 | 5.12 | 0.94 | 2.35 | 2.23 | |
| Free Cash Flow Per Share | (0.3) | (0.79) | (0.15) | (0.33) | 0.0724 | 0.076 | |
| Roic | (0.5) | (0.51) | (0.35) | (0.39) | (1.31) | (0.16) | |
| Inventory Turnover | 2.25 | 1.33 | 1.66 | 0.69 | 0.97 | 2.35 | |
| Net Income Per Share | (0.5) | (0.42) | (0.52) | (0.71) | (0.15) | (0.16) | |
| Days Of Inventory On Hand | 220.03 | 530.69 | 375.49 | 219.46 | 154.56 | 146.83 | |
| Payables Turnover | 4.43 | 8.62 | 3.49 | 7.09 | 6.68 | 7.02 | |
| Research And Ddevelopement To Revenue | 0.3 | 0.32 | 0.21 | 0.13 | 0.0613 | 0.0582 | |
| Cash Per Share | 0.55 | 0.91 | 0.7 | 0.35 | 0.41 | 0.39 | |
| Pocfratio | (32.97) | (11.28) | (41.71) | (3.69) | 43.45 | 45.63 | |
| Interest Coverage | (16.98) | (40.95) | (105.73) | (216.75) | (796.5) | (756.67) | |
| Pfcf Ratio | (32.77) | (10.91) | (40.68) | (3.54) | 47.79 | 50.18 | |
| Days Payables Outstanding | 82.36 | 42.32 | 104.46 | 51.51 | 54.63 | 51.9 | |
| Income Quality | 0.72 | 1.53 | 0.37 | 0.46 | (0.53) | (0.5) | |
| Roe | (0.68) | (0.38) | (0.36) | (1.31) | (0.19) | (0.2) | |
| Ev To Operating Cash Flow | (32.26) | (10.4) | (37.58) | (2.91) | 40.47 | 42.49 | |
| Pe Ratio | (23.61) | (16.49) | (14.19) | (1.63) | (22.82) | (21.68) | |
| Return On Tangible Assets | (0.33) | (0.29) | (0.28) | (0.78) | (0.15) | (0.16) | |
| Ev To Free Cash Flow | (32.06) | (10.06) | (36.65) | (2.79) | 44.5 | 46.73 | |
| Earnings Yield | (0.0424) | (0.0606) | (0.0705) | (0.61) | (0.0438) | (0.046) | |
| Intangibles To Total Assets | 0.18 | 0.1 | 0.16 | 0.14 | 0.12 | 0.11 | |
| Net Debt To E B I T D A | 0.54 | 1.54 | 2.62 | 0.65 | 1.79 | 1.88 | |
| Current Ratio | 3.42 | 11.44 | 5.7 | 5.85 | 3.98 | 2.5 | |
| Tangible Book Value Per Share | 0.74 | 1.5 | 1.19 | 0.71 | 0.67 | 0.7 |
Currently Active Assets on Macroaxis
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 1.313 | Quarterly Revenue Growth (0.08) | Return On Assets (0.08) | Return On Equity (0.16) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.